O. Dalesio
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
-
- Gastric Cancer Management and Outcomes
- Lung Cancer Treatments and Mutations
- Metastasis and carcinoma case studies
Papers in
- Oncology 15
- Cancer Treatment and Pharmacology 7
- Colorectal Cancer Treatments and Studies 4
-
- Lung Cancer Treatments and Mutations 5
- Gastric Cancer Management and Outcomes 5
- Co-authors
- Harry Bleiberg (5 shared papers)N. Duez (5 shared papers)J. Wils (3 shared papers)Nico van Zandwijk (4 shared papers)T. A. W. Splinter (5 shared papers)Giuseppe Giaccone (5 shared papers)Herbert M. Pinedo (3 shared papers)Manon Huizing (3 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Lung Cancer (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)Recent results in cancer research (1 paper)
- Partner nations
- NetherlandsBelgiumItaly
In The Last Decade
O. Dalesio
25 papers receiving 574 citations
Peers
Comparison fields: 5 of 59
- Oncology 312
- Pulmonary and Respiratory Medicine 325
- Gastroenterology 49
- Otorhinolaryngology 33
- Surgery 237
Countries citing papers authored by O. Dalesio
This map shows the geographic impact of O. Dalesio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Dalesio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Dalesio more than expected).
Fields of papers citing papers by O. Dalesio
This network shows the impact of papers produced by O. Dalesio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Dalesio. The network helps show where O. Dalesio may publish in the future.
Co-authors
The 25 scholars most cited alongside O. Dalesio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 159 | |
| 2 | 1986 | 83 | |
| 3 | Adjuvant radiotherapy and chemotherapy in resectable gastric cancer. A randomized trial of the gastro-intestinal tract cancer cooperative group of the EORTC. | 1989 | 55 |
| 4 | 1988 | 39 | |
| 5 | 1990 | 37 | |
| 6 | 1989 | 32 | |
| 7 | 1996 | 27 | |
| 8 | A randomized EORTC study on the effect of preoperative polychemotherapy in pyriform sinus carcinoma treated by pharyngolaryngectomy and irradiation. Results from 5 to 10 years. | 1990 | 24 |
| 9 | A multicenter phase II trial of cisplatin and oral etoposide (VP-16) in inoperable non-small-cell lung cancer. | 1986 | 23 |
| 10 | 1991 | 21 | |
| 11 | 1987 | 19 | |
| 12 | Carboplatin and paclitaxel in patients with advanced ovarian cancer: a dose-finding study. | 1997 | 14 |
| 13 | 2003 | 10 | |
| 14 | Replacement of cisplatin with carboplatin in combination chemotherapy against ovarian cancer: long-term treatment results of a study of the Gynaecological Cancer Cooperative Group of the EORTC and experience at The Netherlands Cancer Institute. | 1992 | 10 |
| 15 | 1986 | 9 | |
| 16 | 1987 | 8 | |
| 17 | Randomized comparison of cyclophosphamide, doxorubicin and cisplatin (CAP) versus cyclophosphamide and doxorubicin (CA) for the treatment of advanced ovarian cancer (ADOVCA). A EORTC Gynecological Cancer Cooperative Group Study. | 1990 | 8 |
| 18 | 1992 | 7 | |
| 19 | 2000 | 6 | |
| 20 | 1991 | 5 |
About O. Dalesio
O. Dalesio is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Epidemiology and Pathology and Forensic Medicine, having authored 25 papers that have together received 607 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Lung Cancer Treatments and Mutations (5 papers), Gastric Cancer Management and Outcomes (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Genetic factors in colorectal cancer (2 papers), Cancer therapeutics and mechanisms (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). The work is most often cited by research in Oncology (312 citations), Pulmonary and Respiratory Medicine (325 citations), Gastroenterology (49 citations), Otorhinolaryngology (33 citations) and Surgery (237 citations). O. Dalesio has collaborated with scholars based in Netherlands, Belgium and Italy. Frequent co-authors include Harry Bleiberg, N. Duez, J. Wils, Nico van Zandwijk, T. A. W. Splinter, Giuseppe Giaccone, Herbert M. Pinedo, Manon Huizing, Marc Buyse and W.W. ten Bokkel Huinink. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Cancer Chemotherapy and Pharmacology, International Journal of Radiation Oncology*Biology*Physics and Recent results in cancer research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.